1. Home
  2. LGIH vs TRVI Comparison

LGIH vs TRVI Comparison

Compare LGIH & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGIH
  • TRVI
  • Stock Information
  • Founded
  • LGIH 2003
  • TRVI 2011
  • Country
  • LGIH United States
  • TRVI United States
  • Employees
  • LGIH N/A
  • TRVI N/A
  • Industry
  • LGIH Homebuilding
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGIH Consumer Discretionary
  • TRVI Health Care
  • Exchange
  • LGIH Nasdaq
  • TRVI Nasdaq
  • Market Cap
  • LGIH 1.2B
  • TRVI 1.1B
  • IPO Year
  • LGIH 2013
  • TRVI 2019
  • Fundamental
  • Price
  • LGIH $46.71
  • TRVI $9.64
  • Analyst Decision
  • LGIH Hold
  • TRVI Strong Buy
  • Analyst Count
  • LGIH 5
  • TRVI 9
  • Target Price
  • LGIH $70.75
  • TRVI $20.72
  • AVG Volume (30 Days)
  • LGIH 391.2K
  • TRVI 2.6M
  • Earning Date
  • LGIH 11-04-2025
  • TRVI 11-05-2025
  • Dividend Yield
  • LGIH N/A
  • TRVI N/A
  • EPS Growth
  • LGIH N/A
  • TRVI N/A
  • EPS
  • LGIH 6.64
  • TRVI N/A
  • Revenue
  • LGIH $2,044,155,000.00
  • TRVI N/A
  • Revenue This Year
  • LGIH N/A
  • TRVI N/A
  • Revenue Next Year
  • LGIH $15.31
  • TRVI N/A
  • P/E Ratio
  • LGIH $7.05
  • TRVI N/A
  • Revenue Growth
  • LGIH N/A
  • TRVI N/A
  • 52 Week Low
  • LGIH $46.47
  • TRVI $2.36
  • 52 Week High
  • LGIH $118.31
  • TRVI $10.16
  • Technical
  • Relative Strength Index (RSI)
  • LGIH 29.33
  • TRVI 64.43
  • Support Level
  • LGIH $50.76
  • TRVI $8.24
  • Resistance Level
  • LGIH $54.15
  • TRVI $8.65
  • Average True Range (ATR)
  • LGIH 2.19
  • TRVI 0.51
  • MACD
  • LGIH -0.70
  • TRVI 0.10
  • Stochastic Oscillator
  • LGIH 1.04
  • TRVI 76.06

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: